MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatotic liver disease.